In addition, when IKK/NF-κB pathway is inhibited by pharmacological inhibitors of IKK2 salicylates and aspirin, the animal models show improved obesity-induced insulin resistance and reduced TNF-α production [173]. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.